Related Experiment Video
Updated: Mar 18, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Glycerin Suppositories Use in Very Low Birth Weight Infants
Shalinkumar Patel1, Narendra Dereddy1, Ajay J Talati1
1Division of Neonatology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
Insights
Glycerin suppositories (GS) use in very low birth weight (VLBW) infants was associated with longer hospital stays and delayed enteral feeding. Further research is needed to confirm safety and efficacy in this vulnerable population.
Area of Science:
- Neonatalogy
- Pediatric Gastroenterology
Background:
- Very low birth weight (VLBW) infants often experience gastrointestinal issues.
- Glycerin suppositories (GS) are commonly used in neonatal intensive care units (NICUs).
Purpose of the Study:
- To investigate the characteristics of VLBW infants receiving GS.
- To evaluate the association between GS use and clinical outcomes in VLBW infants.
Main Methods:
- Retrospective study of 1,073 VLBW infants (500-1,499g) admitted to a level III NICU.
- Comparison of outcomes between infants who received GS and those who did not.
- Multivariate analyses controlling for gestational age and small for gestational age status.
Main Results:
- Nearly half of VLBW infants (49.1%) received GS.
- No significant difference in necrotizing enterocolitis incidence between groups.
- GS group showed significantly longer time to full enteral feeds and hospital stay.
Conclusions:
- Frequent GS use in VLBW infants is associated with prolonged enteral feeding and hospitalization.
- GS may serve as a marker for gastrointestinal dysmotility, indicating potential unfavorable outcomes.
- Prospective studies are warranted to assess the safety and efficacy of GS in VLBW infants.
Abstract:
Objective To study the characteristics of very low birth weight (VLBW) infants receiving glycerin suppositories (GS) and evaluate the association of GS use with outcomes. Study Design This is a retrospective study of VLBW infants admitted to a level III neonatal intensive care unit. Infants with birth weight between 500 and 1,499 g were evaluated. We evaluated the frequency of GS use and compared the characteristics and outcomes of the GS group with the no-GS group. Multivariate analyses controlling for gestational age and small for gestational age status were performed to study the effect of GS on outcomes. Results A total of 1,073 infants were included in the study. Out of those, 527 (49.1%) infants received GS. Incidence of necrotizing enterocolitis was not significantly different between the two groups, while days to reach full enteral feeds and length of hospital stay were significantly longer in the GS group. Conclusion Frequent use of GS warrants further prospective studies to evaluate its safety and efficacy in view of our study showing association with longer time to reach full enteral feeds. We speculate that GS use could be a marker for gastrointestinal dysmotility and hence the association with unfavorable clinical outcomes.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drug Dosing: Infants and Children
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Lower GI Series: Barium Enema
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Oral Hypoglycemic Agents: Glinides

